This Risky Micro-Cap Could Pay Off Big
Pieris Pharmaceuticals is introducing a whole new class of drugs to the marketplace.
Mindfully Curated
Pieris Pharmaceuticals is introducing a whole new class of drugs to the marketplace.
Roblox and BlackLine are still serving a small fraction of their addressable market opportunity.
A sharp acceleration in revenue and earnings growth makes this stock a top 5G pick.
Down nearly 50% from its highs, will investors be catching a falling knife if they buy this popular cryptocurrency now?
Each of these companies is riding a different — and compelling — revenue growth story to new stock price heights.
United Airlines has added another 200 737 MAX jets to its firm order book.
These two businesses are in the same industry but couldn’t be more different.
Most all-weather holdings don’t do much of anything particularly well. This one’s an exception.
Here’s what investors need to know about multiple share classes.
The housing market is hot right now, so here are a few ideas on how to play it.
The Chinese tech giant spins off its Kunlun chipmaking unit as a new $2 billion company.
Just like lots of things in investing, it depends.
If it can deliver on its promises of cost savings for its stakeholders, yes.
You’ll probably need more than Social Security to manage your senior living costs. Here’s where that extra money can come from.
Sometimes it’s possible to have your cake and eat it too.
I bought Enbridge and I’m happy I did, but that doesn’t mean there aren’t risks to think about. Here are three that weigh heavily on my mind.
U.S. oil giant Exxon has had a great run, but that doesn’t change one Fool’s mind about the big switch he made during the 2020 energy downturn.
This midstream stalwart has been selling assets in the face of a weak energy market. Is the partnership’s distribution at risk?
Some great news for a key income-producing sector of the market could provide more optimism.
Positive topline results from the company’s schizophrenia candidate were better than expected.